Participants 94 172 7
patients with type 2 diabetes inadequately controlled by metformin monotherapy
Participants 471 551 5
patients with type 2 diabetes exhibiting inadequate glycemic control (A1C 7-11%)
Participants 646 737 7
302 patients with type 2 diabetes (mean A1C 8.3%) on metformin monotherapy (mean 1.5 g/day)
Participants 1767 1853 4
patients with type 2 diabetes who had inadequate glycemic control with metformin alone
Participants 1963 1978 3
type 2 diabetes
